FDA Approves New Therapy for Myelodysplastic Syndromes (MDS) This represents an important advance in treatment options for patients with MDS, a type of blood cancer, who previously needed to…
FDA Approves First-Line Immunotherapy for Patients with MSI-H/dMMR Metastatic Colorectal Cancer The study demonstrated a statistically significant improvement in progression-free survival (PFS) as assessed by a blinded…
